{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:58:50Z","timestamp":1794851930320,"version":"4.9.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"foundation for a smokefree world","award":["GG0014"],"award-info":[{"award-number":["GG0014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The objective was to systematically review studies on health outcomes from smokeless tobacco (SLT) products.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed published literature on the\u00a0health outcomes from SLT use between 01\/01\/2015 to 01\/02\/2020, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol using PubMed, Embase, Scopus, and Google Scholar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 53 studies included, six were global, 32 from Asia, Middle East and Africa (AMEA), nine from USA and six from Europe. \u2018Poor\u2019-rated studies predominated (23;43%), in particular, for global (4;66%) and AMEA (16;50%). Health outcomes differed between SLT-products and regions; those in AMEA were associated with higher mortality (overall, cancer, Coronary heart disease (CHD), respiratory but not cardiovascular disease (CVD)), and morbidity (CVD, oral and head and neck cancers), with odds ratios up to 38.7. European studies showed no excess mortality (overall, CVD, from cancers) or morbidity (ischemic heart disease (IHD), stroke, oral, head and neck, pancreatic or colon cancers) from several meta-analyses; single studies reported elevated risk of rectal cancer and respiratory disorders. Pooled study data showed protection against developing Parkinson\u2019s disease. US studies showed mixed results for mortality (raised overall, CHD, cancer and smoking-related cancer mortality; no excess risk of respiratory or CVD mortality). Morbidity outcomes were also mixed, with some evidence of increased IHD, stroke and cancer risk (oral, head and neck). No studies reported on switching from cigarettes to SLT-products.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our review demonstrates stark differences between different SLT-products in different regions, ranging from zero harm from European snus to greatly increased health risks in AMEA. The literature on the safety profile for SLT-products for harm reduction is incomplete and potentially misinforming policy and regulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-021-00557-6","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T03:03:27Z","timestamp":1638587007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["The health impact of smokeless tobacco products: a systematic review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-3010","authenticated-orcid":false,"given":"C.","family":"Hajat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ramstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shantikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Polosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"issue":"3","key":"557_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/ijcm.IJCM_194_18","volume":"43","author":"A Kasthuri","year":"2018","unstructured":"Kasthuri A. Challenges to healthcare in India\u2014the five A\u2019s. Indian J Community Med. 2018;43(3):141.","journal-title":"Indian J Community Med"},{"key":"557_CR2","unstructured":"The European Commission. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes. 2017. http:\/\/ec.europa.eu\/commfrontoffice\/publicopinion\/index.cfm\/Survey\/getSurveyDetail\/instruments\/SPECIAL\/surveyKy\/2146. Accessed 20 Feb 2019."},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12954-019-0335-1","volume":"16","author":"E Clarke","year":"2019","unstructured":"Clarke E, Thompson K, Weaver S, et al. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J. 2019;16:62. https:\/\/doi.org\/10.1186\/s12954-019-0335-1.","journal-title":"Harm Reduct J"},{"key":"557_CR4","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.3390\/ijerph111111705","volume":"11","author":"I Lund","year":"2014","unstructured":"Lund I, Lund KE. How has the availability of snus influenced cigarette smoking in Norway? Int J Environ Res Public Health. 2014;11:11705\u201317.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"557_CR5","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/ijerph13111110","volume":"13","author":"L Ramstr\u00f6m","year":"2016","unstructured":"Ramstr\u00f6m L, Borland R, Wikmans T. Patterns of smoking and snus use in sweden: implications for public health. Int J Environ Res Public Health. 2016;13(11):1110. https:\/\/doi.org\/10.3390\/ijerph13111110.","journal-title":"Int J Environ Res Public Health"},{"key":"557_CR6","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization. Smokeless tobacco and some tobacco-specific N-nitrosamines, vol. 89. World Health Organization; 2007."},{"issue":"3","key":"557_CR7","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3(3):e123-130.","journal-title":"Open Med"},{"key":"557_CR8","unstructured":"Center for Evidence-Based Medicine. Oxford centre for evidence-based medicine\u2014levels of evidence. 2009. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Accessed Jan 2020."},{"key":"557_CR9","unstructured":"NIH. Study Quality Assessment Tools. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools. Accessed March 2020."},{"issue":"1","key":"557_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ntr\/nty002","volume":"21","author":"R Gupta","year":"2019","unstructured":"Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. Risk of coronary heart disease among smokeless tobacco users: results of systematic review and meta-analysis of global data. Nicotine Tob Res. 2019;21(1):25\u201331.","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"557_CR11","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1093\/pubmed\/fdz054","volume":"42","author":"R Gupta","year":"2020","unstructured":"Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. Association of smokeless tobacco and cerebrovascular accident: a systematic review and meta-analysis of global data. J Public Health (Oxf). 2020;42(2):e150\u20137.","journal-title":"J Public Health (Oxf)"},{"issue":"18","key":"557_CR12","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1177\/2047487316654026","volume":"23","author":"AL Vidyasagaran","year":"2016","unstructured":"Vidyasagaran AL, Siddiqi K, Kanaan M. Use of smokeless tobacco and risk of cardiovascular disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(18):1970\u201381.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"557_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/tobaccocontrol-2016-053302","volume":"27","author":"DN Sinha","year":"2018","unstructured":"Sinha DN, Suliankatchi RA, Gupta PC, Thamarangsi T, Agarwal N, Parascandola M, et al. Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018;27(1):35\u201342.","journal-title":"Tob Control"},{"key":"557_CR14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-015-0424-2","volume":"13","author":"K Siddiqi","year":"2015","unstructured":"Siddiqi K, Shah S, Abbas SM, Vidyasagaran A, Jawad M, Dogar O, et al. Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med. 2015;13:194.","journal-title":"BMC Med"},{"issue":"6","key":"557_CR15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/tobaccocontrol-2016-053245","volume":"26","author":"A Etemadi","year":"2017","unstructured":"Etemadi A, et al. Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a Cohort Study of 50 000 individuals from Iran. Tob Control. 2017;26(6):674\u201382.","journal-title":"Tob Control"},{"issue":"3","key":"557_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.7314\/APJCP.2015.16.3.1201","volume":"16","author":"V Gajalakshmi","year":"2015","unstructured":"Gajalakshmi V, Kanimozhi V. Tobacco chewing and adult mortality: a case-control analysis of 22,000 cases and 429,000 controls, never smoking tobacco and never drinking alcohol, in South India. Asian Pac J Cancer Prev. 2015;16(3):1201\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"557_CR17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.18203\/2349-3933.ijam20190452","volume":"6","author":"R Behera","year":"2015","unstructured":"Behera R, Padhi R. Impact of smokeless tobacco products on myocardial infarction and stroke and it\u2019s prognostic significance. Int J Adv Med. 2015;6(2):240.","journal-title":"Int J Adv Med"},{"key":"557_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fpubh.2017.00255","volume":"5","author":"A Anand","year":"2017","unstructured":"Anand A, Sk MIK. The risk of hypertension and other chronic diseases: comparing smokeless tobacco with smoking. Front Public Health. 2017;5:255.","journal-title":"Front Public Health"},{"issue":"4","key":"557_CR19","first-page":"1","volume":"6","author":"DK Mishra","year":"2018","unstructured":"Mishra DK, Mishra N, Kumar P, Raghuvanshi G. Latent coronary artery disease among smokers and smokeless tobacco users: a cross-sectional study. Int J Res Med Sci. 2018;6(4):1.","journal-title":"Int J Res Med Sci"},{"key":"557_CR20","unstructured":"Ahwal S, Gaddam R, Roy R, Lakshmy. Journal of Nursing Science & Practice A Study to Compare The Cardiovascular Disease (CVD) Risk Associated with Smokeless Tobacco Consumption and Smoking. 1\u20138; 2015."},{"issue":"3","key":"557_CR21","first-page":"113","volume":"8","author":"KZ Naswar","year":"2016","unstructured":"Naswar KZ. (smokeless tobacco product), oral cancer and tobacco control in khyber pakhtunkhwa, Pakistan. Khyber Med Univ J. 2016;8(3):113.","journal-title":"Khyber Med Univ J"},{"issue":"6","key":"557_CR22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/ijc.29884","volume":"138","author":"DN Sinha","year":"2016","unstructured":"Sinha DN, Abdulkader RS, Gupta PC. Smokeless tobacco-associated cancers: a systematic review and meta-analysis of Indian studies. Int J Cancer. 2016;138(6):1368\u201379.","journal-title":"Int J Cancer"},{"key":"557_CR23","first-page":"56","volume":"17","author":"MFA Quadri","year":"2019","unstructured":"Quadri MFA, Tadakamadla SK, John T. Smokeless tobacco and oral cancer in the Middle East and North Africa: a systematic review and meta-analysis. Tob Induc Dis. 2019;17:56.","journal-title":"Tob Induc Dis"},{"issue":"10","key":"557_CR24","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.7314\/APJCP.2015.16.10.4335","volume":"16","author":"MF Quadri","year":"2015","unstructured":"Quadri MF, Alharbi F, Bajonaid AM, Moafa IH, Sharwani AA, Alamir AH. Oral squamous cell carcinoma and associated risk factors in Jazan, Saudi Arabia: a hospital based case control study. Asian Pac J Cancer Prev. 2015;16(10):4335\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"557_CR25","first-page":"791","volume":"19","author":"F Alharbi","year":"2018","unstructured":"Alharbi F, Quadri MF. Individual and integrated effects of potential risk factors for oral squamous cell carcinoma: a hospital-based case-control study in Jazan, Saudi Arabia. Asian Pac J Cancer Prev APJCP. 2018;19(3):791.","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"9","key":"557_CR26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.5005\/jp-journals-10024-1922","volume":"17","author":"KH Awan","year":"2016","unstructured":"Awan KH, Hussain QA, Patil S, Maralingannavar M. Assessing the risk of oral cancer associated with gutka and other smokeless tobacco products: a case-control study. J Contemp Dent Pract. 2016;17(9):740\u20134.","journal-title":"J Contemp Dent Pract"},{"key":"557_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.canep.2017.09.003","volume":"51","author":"B Gupta","year":"2017","unstructured":"Gupta B, Bray F, Kumar N, Johnson NW. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case\u2013control study from India. Cancer Epidemiol. 2017;51:7\u201314.","journal-title":"Cancer Epidemiol"},{"key":"557_CR28","doi-asserted-by":"crossref","first-page":"2057178X1668572","DOI":"10.1177\/2057178X16685729","volume":"2","author":"AA Hassanin","year":"2017","unstructured":"Hassanin AA, Idris AM. Attribution of oral cancer in the Sudan to Toombak dipping. Transl Res Oral Oncol. 2017;2:2057178X16685729.","journal-title":"Transl Res Oral Oncol"},{"issue":"7","key":"557_CR29","doi-asserted-by":"crossref","first-page":"e0180445","DOI":"10.1371\/journal.pone.0180445","volume":"12","author":"Z Khan","year":"2017","unstructured":"Khan Z, Dreger S, Shah SMH, Pohlabeln H, Khan S, Ullah Z, et al. Oral cancer via the bargain bin: the risk of oral cancer associated with a smokeless tobacco product (Naswar). PLoS ONE. 2017;12(7):e0180445.","journal-title":"PLoS ONE"},{"issue":"1","key":"557_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0973-1482.143332","volume":"11","author":"S Mahapatra","year":"2015","unstructured":"Mahapatra S, Kamath R, Shetty BK, Binu VS. Risk of oral cancer associated with gutka and other tobacco products: a hospital-based case-control study. J Cancer Res Ther. 2015;11(1):199\u2013203.","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"557_CR31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/0973-1482.151417","volume":"11","author":"V Kadashetti","year":"2015","unstructured":"Kadashetti V, Chaudhary M, Patil S, Gawande M, Shivakumar KM, Pramod RC. Analysis of various risk factors affecting potentially malignant disorders and oral cancer patients of Central India. J Cancer Res Ther. 2015;11(2):280\u20136.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"557_CR32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3906\/sag-1809-11","volume":"50","author":"SZ Khan","year":"2020","unstructured":"Khan SZ, Farooq A, Masood M, Shahid A, Khan IU, Nisar H, et al. Smokeless tobacco use and risk of oral cavity cancer. Turk J Med Sci. 2020;50(1):291\u20137.","journal-title":"Turk J Med Sci"},{"issue":"4","key":"557_CR33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/0019-509X.204759","volume":"53","author":"S Nair","year":"2016","unstructured":"Nair S, Datta S, Thiagarajan S, Chakrabarti S, Nair D, Chaturvedi P. Squamous cell carcinoma of the upper aerodigestive tract in exclusive smokers, chewers, and those with no habits. Indian J Cancer. 2016;53(4):538\u201341.","journal-title":"Indian J Cancer"},{"issue":"4","key":"557_CR34","first-page":"10210","volume":"4","author":"S Soni","year":"2016","unstructured":"Soni S, Vaishnav K, Bhayal A, Purohit R, Soni A. A study on oral cancer and its correlation with tobacco chewing, smoking and alcohol drinking in Western Rajasthan. J Med Sci Clin Res. 2016;4(4):10210\u20138.","journal-title":"J Med Sci Clin Res"},{"issue":"4","key":"557_CR35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/ijmpo.ijmpo_97_18","volume":"39","author":"DD Gholap","year":"2018","unstructured":"Gholap DD, Chaturvedi P, Dikshit RP. Ecological analysis to study association between prevalence of smokeless tobacco type and head-and-neck cancer. Indian J Med Paediatr Oncol. 2018;39(4):456.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"3","key":"557_CR36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ijc.32823","volume":"147","author":"CP Chang","year":"2020","unstructured":"Chang CP, Siwakoti B, Sapkota A, Gautam DK, Lee YA, Monroe M, et al. Tobacco smoking, chewing habits, alcohol drinking and the risk of head and neck cancer in Nepal. Int J Cancer. 2020;147(3):866\u201375.","journal-title":"Int J Cancer"},{"issue":"2","key":"557_CR37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3126\/nje.v5i2.12832","volume":"5","author":"N Rajbongshi","year":"2015","unstructured":"Rajbongshi N, Mahanta LB, Nath DC. Evaluation of female breast cancer risk among the betel quid chewer: a bio-statistical assessment in Assam, India. Nepal J Epidemiol. 2015;5(2):494.","journal-title":"Nepal J Epidemiol"},{"issue":"7","key":"557_CR38","first-page":"560","volume":"7","author":"RV Mohite","year":"2016","unstructured":"Mohite RV, Mohite VR, Pratinidhi AK. Exposure to smokeless form of tobacco and risk of breast cancer: a case control study from rural Maharashtra, India. Natl J Community Med. 2016;7(7):560\u20134.","journal-title":"Natl J Community Med"},{"issue":"10","key":"557_CR39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.26719\/2016.22.10.719","volume":"22","author":"SA Shah","year":"2016","unstructured":"Shah SA, Ghazi HF. Tobacco chewing and risk of gastric cancer: a case\u2013control study in Yemen. EMHJ East Mediterr Health J. 2016;22(10):719\u201326.","journal-title":"EMHJ East Mediterr Health J"},{"issue":"4","key":"557_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.22159\/ajpcr.2017.v10i4.16194","volume":"10","author":"S Nair","year":"2017","unstructured":"Nair S. Colorectal cancer and its risk factors among patients attending a tertiary care hospital in Southern Karnataka, India. Asian J Pharm Clin Res. 2017;10(4):109\u201312.","journal-title":"Asian J Pharm Clin Res"},{"issue":"4","key":"557_CR41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/ijph.IJPH_327_17","volume":"62","author":"S Mahapatra","year":"2018","unstructured":"Mahapatra S, Chaly PE, Mohapatra SC, Madhumitha M. Influence of tobacco chewing on oral health: a hospital-based cross-sectional study in Odisha. Indian J Public Health. 2018;62(4):282\u20136.","journal-title":"Indian J Public Health"},{"issue":"5","key":"557_CR42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10935-017-0485-4","volume":"38","author":"SL Hernandez","year":"2017","unstructured":"Hernandez SL, Banks HE, Bailey AE, Bachman MJ, Kane J, Hartos JL. Relationships among chewing tobacco, cigarette smoking, and chronic health conditions in males 18\u201344 years of age. J Primary Prevent. 2017;38(5):505\u201314.","journal-title":"J Primary Prevent"},{"issue":"1","key":"557_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-019-0294-6","volume":"16","author":"MT Fisher","year":"2019","unstructured":"Fisher MT, Tan-Torres SM, Gaworski CL, Black RA, Sarkar MA. Smokeless tobacco mortality risks: an analysis of two contemporary nationally representative longitudinal mortality studies. Harm Reduct J. 2019;16(1):27.","journal-title":"Harm Reduct J"},{"issue":"1","key":"557_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-019-0321-7","volume":"16","author":"B Rodu","year":"2019","unstructured":"Rodu B, Plurphanswat N. Mortality among male smokers and smokeless tobacco users in the USA. Harm Reduct J. 2019;16(1):50.","journal-title":"Harm Reduct J"},{"issue":"2","key":"557_CR45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.30736","volume":"141","author":"DS Timberlake","year":"2017","unstructured":"Timberlake DS, Nikitin D, Johnson NJ, Altekruse SF. A longitudinal study of smokeless tobacco use and mortality in the United States. Int J Cancer. 2017;141(2):264\u201370.","journal-title":"Int J Cancer"},{"issue":"3","key":"557_CR46","doi-asserted-by":"crossref","first-page":"pkz036","DOI":"10.1093\/jncics\/pkz036","volume":"3","author":"M Inoue-Choi","year":"2019","unstructured":"Inoue-Choi M, Shiels MS, McNeel TS, Graubard BI, Hatsukami D, Freedman ND. Contemporary associations of exclusive cigarette, cigar, pipe, and smokeless tobacco use with overall and cause-specific mortality in the United States. JNCI Cancer Spectr. 2019;3(3):pkz036.","journal-title":"JNCI Cancer Spectr"},{"issue":"2","key":"557_CR47","doi-asserted-by":"crossref","first-page":"e000846","DOI":"10.1136\/openhrt-2018-000846","volume":"5","author":"BL Rostron","year":"2018","unstructured":"Rostron BL, Chang JT, Anic GM, Tanwar M, Chang CM, Corey CG. Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis. Open Heart. 2018;5(2):e000846.","journal-title":"Open Heart"},{"issue":"1","key":"557_CR48","first-page":"60","volume":"5","author":"O Obisesan","year":"2016","unstructured":"Obisesan O, Thompson E, Obisesan A, Akinola O, Commodore-Mensah Y. Association between non-cigarette\/smokeless tobacco and hypertension in the national health interview survey: a pseudo-panel analysis. Int J Public Health Sci. 2016;5(1):60\u20139.","journal-title":"Int J Public Health Sci"},{"issue":"10","key":"557_CR49","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/aje\/kww075","volume":"184","author":"AB Wyss","year":"2016","unstructured":"Wyss AB, Hashibe M, Lee YA, Chuang SC, Muscat J, Chen C, et al. Smokeless tobacco use and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE consortium. Am J Epidemiol. 2016;184(10):703\u201316.","journal-title":"Am J Epidemiol"},{"key":"557_CR50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addbeh.2017.09.012","volume":"77","author":"JL King","year":"2018","unstructured":"King JL, Reboussin BA, Spangler J, Cornacchione Ross J, Sutfin EL. Tobacco product use and mental health status among young adults. Addict Behav. 2018;77:67\u201372.","journal-title":"Addict Behav"},{"issue":"8","key":"557_CR51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1403494817714191","volume":"45","author":"M Araghi","year":"2017","unstructured":"Araghi M, Galanti MR, Lundberg M, Liu Z, Ye W, Lager A, et al. Smokeless tobacco (snus) use and colorectal cancer incidence and survival: results from nine pooled cohorts. Scand J Public Health. 2017;45(8):741\u20138.","journal-title":"Scand J Public Health"},{"issue":"12","key":"557_CR52","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/ijc.30411","volume":"139","author":"KM Wilson","year":"2016","unstructured":"Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, et al. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016;139(12):2753\u20139.","journal-title":"Int J Cancer"},{"issue":"9","key":"557_CR53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ntr\/nty074","volume":"21","author":"S Asthana","year":"2019","unstructured":"Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res. 2019;21(9):1162\u201371.","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"557_CR54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ijc.30773","volume":"141","author":"M Araghi","year":"2017","unstructured":"Araghi M, Rosaria Galanti M, Lundberg M, Lager A, Engstr\u00f6m G, Alfredsson L, et al. Use of moist oral snuff (snus) and pancreatic cancer: pooled analysis of nine prospective observational studies. Int J Cancer. 2017;141(4):687\u201393.","journal-title":"Int J Cancer"},{"issue":"3","key":"557_CR55","first-page":"872","volume":"46","author":"F Yang","year":"2017","unstructured":"Yang F, Pedersen NL, Ye W, Liu Z, Norberg M, Forsgren L, et al. Moist smokeless tobacco (Snus) use and risk of Parkinson\u2019s disease. Int J Epidemiol. 2017;46(3):872\u201380.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"557_CR56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/bmjopen-2016-015486","volume":"7","author":"A\u00dd Gudnad\u00f3ttir","year":"2017","unstructured":"Gudnad\u00f3ttir A\u00dd, \u00d3lafsd\u00f3ttir IS, Middelveld R, Ekerljung L, Forsberg B, Franklin K, Lindberg E, Janson C. An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study. BMJ Open. 2017;7(5):56.","journal-title":"BMJ Open"},{"issue":"1","key":"557_CR57","doi-asserted-by":"publisher","first-page":"e0227837","DOI":"10.1371\/journal.pone.0227837","volume":"15","author":"TS Lawler","year":"2020","unstructured":"Lawler TS, Stanfill SB, Tran HT, Lee GE, Chen PX, Kimbrell JB, Lisko JG, Fernandez C, Caudill SP, deCastro BR, Watson CH. Chemical analysis of snus products from the United States and northern Europe. PLoS ONE. 2020;15(1):e0227837. https:\/\/doi.org\/10.1371\/journal.pone.0227837.","journal-title":"PLoS ONE"},{"key":"557_CR58","unstructured":"Centers for Disease Control and Prevention. Adult tobacco use information. https:\/\/www.cdc.gov\/nchs\/nhis\/tobacco\/tobacco_glossary.htm. Accessed August 2020."},{"issue":"1","key":"557_CR59","first-page":"41","volume":"34","author":"T Hirayama","year":"1966","unstructured":"Hirayama T. An epidemiological study of oral and pharyngeal cancer in Central and South-East Asia. Bull World Health Organ. 1966;34(1):41\u201369.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"557_CR60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/bjc.1977.31","volume":"35","author":"K Jayant","year":"1977","unstructured":"Jayant K, Balakrishnan V, Sanghvi LD, Jussawalla DJ. Quantification of the role of smoking and chewing tobacco in oral, pharyngeal, and oesophageal cancers. Br J Cancer. 1977;35(2):232\u20135.","journal-title":"Br J Cancer"},{"key":"557_CR61","unstructured":"Shapiro H. burning issues: global state of tobacco harm reduction 2020. Knowledge change action. 2020. https:\/\/gsthr.org\/resources\/item\/burning-issues-global-state-tobacco-harm-reduction-2020."},{"key":"557_CR62","unstructured":"Tata Institute of Social Science. Global Adult Tobacco Survey 2, India 2016\u201317. https:\/\/www.tiss.edu\/view\/11\/research-projects\/global-adult-tobacco-survey-round-2-for-india-2016\/."},{"key":"557_CR63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/tc.12.4.360","volume":"12","author":"C Bates","year":"2003","unstructured":"Bates C, Fagerstrom K, Jarvis MJ, Kunze M, McNeill A, Ramstrom L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob Control. 2003;12:360\u20137.","journal-title":"Tob Control"},{"key":"557_CR64","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1360-0443.2003.00442.x","volume":"98","author":"KO Fagerstrom","year":"2003","unstructured":"Fagerstrom KO, Schildt EB. Should the European Union lift the ban on snus? Evidence from the Swedish experience. Addiction. 2003;98:1191\u20135.","journal-title":"Addiction"},{"key":"557_CR65","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.drugpo.2009.10.008","volume":"21","author":"C Gartner","year":"2010","unstructured":"Gartner C, Hall W. Harm reduction policies for tobacco users. Int J Drug Policy. 2010;21:129\u201330.","journal-title":"Int J Drug Policy"},{"key":"557_CR66","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(07)60677-1","volume":"369","author":"CE Gartner","year":"2007","unstructured":"Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet. 2007;369:2010\u20134.","journal-title":"Lancet"},{"key":"557_CR67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/14034940510032301","volume":"33","author":"B Stegmayr","year":"2005","unstructured":"Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health. 2005;33:321\u20134.","journal-title":"Scand J Public Health"},{"key":"557_CR68","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1360-0443.2009.02661.x","volume":"104","author":"M Stenbeck","year":"2009","unstructured":"Stenbeck M, Hagquist C, Rosen M. The association of snus and smoking behaviour: a cohort analysis of Swedish males in the 1990s. Addiction. 2009;104:1579\u201385.","journal-title":"Addiction"},{"key":"557_CR69","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/tc.2005.014969","volume":"15","author":"LM Ramstrom","year":"2006","unstructured":"Ramstrom LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control. 2006;15:210\u20134.","journal-title":"Tob Control"},{"key":"557_CR70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0749-3797(02)00491-9","volume":"23","author":"SL Tomar","year":"2002","unstructured":"Tomar SL. Snuff use and smoking in U.S. men: implications for harm reduction. Am J Prev Med. 2002;23:143\u20139.","journal-title":"Am J Prev Med"},{"key":"557_CR71","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/j.amepre.2007.09.009","volume":"33","author":"SL Tomar","year":"2007","unstructured":"Tomar SL. Epidemiologic perspectives on smokeless tobacco marketing and population harm. Am J Prev Med. 2007;33:S387\u201397.","journal-title":"Am J Prev Med"},{"key":"557_CR72","unstructured":"Compare Viz Hub. Institute for health metrics and evaluation. https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"issue":"1","key":"557_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00405-z","volume":"17","author":"T Sohlberg","year":"2020","unstructured":"Sohlberg T, Wennberg P. Snus cessation patterns-a long-term follow-up of snus users in Sweden. Harm Reduct J. 2020;17(1):1\u20139.","journal-title":"Harm Reduct J"},{"issue":"9578","key":"557_CR74","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(07)60677-1","volume":"369","author":"CE Gartner","year":"2007","unstructured":"Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. The Lancet. 2007;369(9578):2010\u20134.","journal-title":"The Lancet"},{"key":"557_CR75","unstructured":"Tobacco Control Laws. Legislation and FCTC analaysis. https:\/\/www.tobaccocontrollaws.org\/legislation\/."},{"issue":"1","key":"557_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-020-01677-9","volume":"18","author":"K Siddiqi","year":"2020","unstructured":"Siddiqi K, Husain S, Vidyasagaran A, Readshaw A, Mishu MP, Sheikh A. Global burden of disease due to smokeless tobacco consumption in adults: an updated analysis of data from 127 countries. BMC Med. 2020;18(1):1\u201322.","journal-title":"BMC Med"},{"key":"557_CR77","unstructured":"Official Journal of the European Union. Directive 2014\/40\/EU of the european parliament and of the council. https:\/\/ec.europa.eu\/health\/sites\/health\/files\/tobacco\/docs\/dir_201440_en.pdf."},{"issue":"6","key":"557_CR78","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10389-018-0992-7","volume":"27","author":"JB Prasad","year":"2019","unstructured":"Prasad JB, Dhar M. Risk of major cancers associated with various forms of tobacco use in India: a systematic review and meta-analysis. J Public Health. 2019;27(6):803\u201313.","journal-title":"J Public Health"},{"issue":"3","key":"557_CR79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10552-014-0516-x","volume":"26","author":"AT Merchant","year":"2015","unstructured":"Merchant AT, Pitiphat W. Total, direct, and indirect effects of paan on oral cancer. Cancer Causes Control. 2015;26(3):487\u201391.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"557_CR80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7126\/cumudj.592787","volume":"22","author":"BU Sajad","year":"2019","unstructured":"Sajad BU, Subhas BA, Shruthi RA. Indiscriminate use of smokeless tobacco leading to oral cancer at a young age; a case report with literature review on tobacco consumption. Cumhuriyet Dent J. 2019;22(4):477\u201380.","journal-title":"Cumhuriyet Dent J"},{"key":"557_CR81","first-page":"2017","volume":"16","author":"D Bhatt","year":"2017","unstructured":"Bhatt D, Sharma S, Gupta R, Sinha DN, Mehrotra R. Predictors of hypertension among nonpregnant females attending health promotion clinic with special emphasis on smokeless tobacco: a cross-sectional study. Biomed Res Int. 2017;16:2017.","journal-title":"Biomed Res Int"},{"issue":"30","key":"557_CR82","first-page":"31","volume":"20","author":"S Mathew","year":"2015","unstructured":"Mathew S, Noronha JA, Kamath P. Effects of smokeless tobacco (Slt) on the general and reproductive health of women in selected villages of Udupi district. Karnataka Age. 2015;20(30):31\u201340.","journal-title":"Karnataka Age"},{"issue":"4","key":"557_CR83","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/alcalc\/agx031","volume":"52","author":"KK Rauwolf","year":"2017","unstructured":"Rauwolf KK, Berglund KJ, Berggren U, Balldin J, Fahlke C. The influence of smoking and smokeless tobacco on the progression, severity and treatment outcome in alcohol-dependent individuals. Alcohol Alcohol. 2017;52(4):477\u201382.","journal-title":"Alcohol Alcohol"},{"key":"557_CR84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7517-3-37","volume":"3","author":"B Rodu","year":"2006","unstructured":"Rodu B, Godshall WT. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J. 2006;3:37.","journal-title":"Harm Reduct J"},{"issue":"6","key":"557_CR85","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/jf00066a039","volume":"33","author":"KD Brunnemann","year":"1985","unstructured":"Brunnemann KD, Lise G, Dietrich H. N-Nitrosamines in chewing tobacco: an international comparison. J Agric Food Chem. 1985;33(6):1178\u201381.","journal-title":"J Agric Food Chem"},{"key":"557_CR86","first-page":"35","volume":"74","author":"C Muir","year":"1996","unstructured":"Muir C, et al. Smokeless tobacco and cancer: an overview. IARC Sci Publ. 1996;74:35\u201344.","journal-title":"IARC Sci Publ"},{"issue":"6","key":"557_CR87","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF00398180","volume":"114","author":"KK Wary","year":"1988","unstructured":"Wary KK, Sharan RN. Aqueous extract of betel-nut of north-east India induces DNA-strand breaks and enhances rate of cell proliferation in vitro. Effects of betel-nut extract in vitro. J Cancer Res Clin Oncol. 1988;114(6):579\u201382.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8819","key":"557_CR88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0140-6736(92)92109-S","volume":"340","author":"SJ Thomas","year":"1992","unstructured":"Thomas SJ, MacLennan R. Slaked lime and betel nut cancer in Papua New Guinea. Lancet. 1992;340(8819):577\u20138.","journal-title":"Lancet"},{"key":"557_CR89","unstructured":"World Health Organization. WHO study group on tobacco product regulation: report on the scientific basis of tobacco product regulation: seventh report of a WHO study group. 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329445\/9789241210249-eng.pdf."},{"key":"557_CR90","unstructured":"US Department of Agriculture Economic Research Service: Briefing Rooms: Tobacco. http:\/\/www.ers.usda.gov\/Briefing\/Tobacco\/."},{"key":"557_CR91","unstructured":"Wahlberg I, et al. Smokeless tobacco. Tobacco: production, chemistry, and technology. Edited by: Davis DEL, Nielsen MR. 1999."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-021-00557-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-021-00557-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:35:42Z","timestamp":1726241742000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-021-00557-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s12954-021-00557-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CH received reimbursement from ECLAT for research conducted on tobacco harm reduction (2019\u20132020) including this article; she has served as a paid member of the advisory panel for the Tobacco Transformation Index (contracted by Sustainability, Sept 2019\u2013April 2020); she served as a paid consultant to TEVA pharmaceuticals on work related to multiple chronic conditions (2017\u20132020). ES received reimbursement from ECLAT for research conducted on tobacco harm reduction (2019\u20132020) including this article. LR has no conflict of interest to declare and he received no financial support for participation in this study. SS has no conflict of interest to declare.\u00a0RP is full-time employee of the University of Catania, Italy. In relation to his work in the area of tobacco control and respiratory diseases, RP has received lecture fees and research funding from Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A\/S, Sandoz, MSD, Boehringer Ingelheim, Novartis, Duska Therapeutics, and Forest Laboratories. He has also served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, CV Therapeutics, NeuroSearch A\/S, Boehringer Ingelheim, Novartis, Duska Therapeutics, Alfa-Wassermann, Forest Laboratories, ECITA (Electronic Cigarette Industry Trade Association, in the UK), Arbi Group Srl., and Health Diplomats. RP is the Founder of the Center of Excellence for the acceleration of Harm Reduction at the University of Catania (CoEHAR), which has received a grant from Foundation for a Smoke Free World to develop and carry out eight research projects. RP is also currently involved in the following pro bono activities: scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti-Smoking League) and Chair of the European Technical Committee for standardization on 'Requirements and test methods for emissions of electronic cigarettes' (CEN\/TC 437; WG4). SS has no conflict of interest to declare, and has never accepted funding from any tobacco or nicotine commercial or charitable interest, including the FSFW.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}